![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 14, 8826-8834, May, 1991
TM Penning, WR Abrams and JE Pawlowski
Homogeneous 3 alpha-hydroxysteroid dehydrogenase (3 alpha-HSD, EC 1.1.1.50)
of rat liver cytosol is potently inhibited at its active site by
nonsteroidal anti-inflammatory drugs (NSAIDs). Using 3 alpha-
bromoacetoxy-5 alpha-androstan-17-one (BrAnd, a substrate analog) and 11
alpha-bromoacetoxyprogesterone (Br11P, a glucocorticoid analog) as
affinity-labeling agents, kinetic evidence was obtained that these agents
alkylate this site. Inactivation of 3 alpha-HSD with either [14C]BrAnd or
[14C] Br11P led to the incorporation of 1 mol of affinity- labeling agent
per enzyme monomer. Complete acid hydrolysis of 3 alpha- HSD radiolabeled
with either agent followed by amino acid analysis led to the identification
of [14C]carboxymethylcysteine indicating that [14C]BrAnd and [14C]Br11P
covalently tag discrete reactive cysteine(s) at the enzyme active site.
Trypsin digestion of [14C]BrAnd-inactivated 3 alpha-HSD followed by peptide
mapping led to the purification of a single radiolabeled peptide (3A1)
which gave the following sequence:
H2N-Ser-Ile-Gly-Val-Ser-Asn-Phe-Asn-X-Arg-CO2H. Identical experiments on
[14C] Br11P-inactivated 3 alpha-HSD led to the purification of three
radiolabeled peptides (11P1-11P3). The major radiolabeled peptide (11P1)
had an identical sequence to 3A1 which was tagged with [14C]BrAnd. The
minor radiolabeled peptides had the following sequences:
H2N-Ser-Lys-Asp-Ile-Ile-Leu-Val-Ser-Tyr-X-Thr-Leu-Gly-Ser- Ser-Arg-CO2H
(11P2) and H2N-Ser-Pro-Val-Leu-Leu-Asp-Asp-Pro-Val-Leu-X-
Ala-Ile-Ala-Lys-CO2H (11P3). In each peptide group X was identified as
carboxymethylcysteine. Alignment of the peptide sequences with the primary
structure of 3 alpha-HSD, deduced from its cDNA clone, assigned peptide
11P1 to residues 162-171, peptide 11P2 to residues 208-223, and peptide
11P3 to residues 232-246 of the amino acid sequence. The reactive cysteines
correspond to Cys170, Cys217, and Cys242. We propose that Cys170 labeled by
BrAnd may lie within the catalytic pocket of the enzyme. By contrast the 11
alpha-bromoacetoxy group in Br11P labeled several reactive cysteines which
may be involved in the binding of glucocorticoids and NSAIDs.
Affinity labeling of 3 alpha-hydroxysteroid dehydrogenase with 3 alpha- bromoacetoxyandrosterone and 11 alpha-bromoacetoxyprogesterone. Isolation and sequence of active site peptides containing reactive cysteines; sequence confirmation using nucleotide sequence from a cDNA clone
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia 19104.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. M. Jez, B. P. Schlegel, and T. M. Penning Characterization of the Substrate Binding Site in Rat Liver 3alpha -Hydroxysteroid/Dihydrodiol Dehydrogenase. THE ROLES OF TRYPTOPHANS IN LIGAND BINDING AND PROTEIN FLUORESCENCE J. Biol. Chem., November 22, 1996; 271(47): 30190 - 30198. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Thomas, W. E. Nash, M. W. Crankshaw, and R. C. Strickler Affinity Labeling in the Presence of the Reduced Diphosphopyridine Nucleotide NADH Identifies Peptides Associated With the Activities of Human Placental 3{beta}-Hydroxy-{Delta}5- Steroid Dehydrogenase/Isomerase Reproductive Sciences, April 1, 1994; 1(2): 155 - 163. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |